Market Blog

Spark Therapeutics and Twilio may have bearish sentiments today

ONCE– Spark Therapeutics is engaged in developing products based on gene therapy. ONCE – Spark Therapeutics Fundamentals Previously closed at 63.87 Day's high 60.48 Day's low 58.84 P/E ratio ­ -19.81   Analysts opinion The average target price for the stock is $51. Many analysts have recently issued reports for the company. Jefferies Group reissued a “hold” rating. Cowen and Company reissued a “buy” rating. Hedge funds have also made